BioScience Health Innovations Reports Officer Changes
Ticker: BHIC · Form: 8-K · Filed: 2026-04-02T15:17:50-04:00
Sentiment: neutral
Topics: officer-change, director-change, appointment
Related Tickers: BHIC
TL;DR
BioScience Health Innovations (BHIC) filed an 8-K on 4/2/26 for officer changes.
AI Summary
BioScience Health Innovations, Inc. (CIK: 0001784440) filed an 8-K on April 2, 2026, reporting a departure of directors or certain officers, election of directors, and appointment of certain officers. The filing also includes compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and compensation are not provided in this summary extract.
Why It Matters
Changes in key leadership and officer appointments can signal shifts in company strategy or operational focus.
Risk Assessment
Risk Level: medium — Officer changes can indicate internal shifts that may impact future performance.
Key Players & Entities
- BioScience Health Innovations, Inc. (company) — Filer
- 0001784440 (company) — CIK
- 0001185185-26-001231 (filing_id) — SEC Accession Number
- 2026-04-02 (date) — Filing Date
FAQ
What specific officer positions were affected by the changes reported in the 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not specify the exact positions in the provided text.
Were there any new directors elected to the board?
The filing mentions the 'Election of Directors' as an item covered, but does not provide names or details of any newly elected directors.
What is the CIK number for BioScience Health Innovations, Inc.?
The CIK number for BioScience Health Innovations, Inc. is 0001784440.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 2, 2026, at 15:17:50.
Does the filing detail the compensatory arrangements for the officers involved?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the provided text does not include the specifics of these arrangements.
From the Filing
EDGAR Filing Documents for 0001185185-26-001231 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001185185-26-001231 Filing Date 2026-04-02 Accepted 2026-04-02 15:17:50 Documents 11 Period of Report 2026-04-02 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K bhic8k040226.htm iXBRL 8-K 25904 Complete submission text file 0001185185-26-001231.txt 189044 Data Files Seq Description Document Type Size 2 XBRL SCHEMA FILE bhic-20260402.xsd EX-101.SCH 3016 3 XBRL LABEL FILE bhic-20260402_lab.xml EX-101.LAB 34911 4 XBRL PRESENTATION FILE bhic-20260402_pre.xml EX-101.PRE 22788 14 EXTRACTED XBRL INSTANCE DOCUMENT bhic8k040226_htm.xml XML 3062 Mailing Address 2722 S WEST TEMPLE SALT LAKE CITY UT 84115 Business Address 2722 S WEST TEMPLE SALT LAKE CITY UT 84115 801-949-0791 BioScience Health Innovations, Inc. (Filer) CIK : 0001784440 (see all company filings) EIN. : 000000000 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 333-234487 | Film No.: 26832770 SIC : 7374 Services-Computer Processing & Data Preparation (CF Office: 06 Technology)